Publications by authors named "Andrea Zuckerman"

Claim this Profile
R
Rapid, high-resolution, non-destructive assessments of metabolic and morphological homogeneity uniquely identify high-grade cervical precancerous lesions.
Christopher M Polleys, Pramesh Singh, Hong-Thao Thieu, Elizabeth M Genega, Narges Jahanseir, Andrea L Zuckerman

bioRxiv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case 26-2023: A 15-Year-Old Girl with Abdominal Pain and an Ovarian Mass.
Andrea L Zuckerman, Ali Pourvaziri, David H Ebb, Baris Boyraz

N Engl J Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASRM müllerian anomalies classification 2021.
Samantha M Pfeifer, Marjan Attaran, Jessica Goldstein, Steven R Lindheim, John C Petrozza, Andrea Zuckerman

Fertil Steril· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Iconic brands: standing the test of time with a little rebranding.
Steven R Lindheim, Samantha M Pfeifer, Beth W Rackow, John Petrozza, Marjan Attaran, Andrea Zuckerman

Fertil Steril· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving the identification of genitourinary syndrome of menopause through the utilization of the Day-to-Day Impact of Vaginal Aging questionnaire.
Jennie Mastroianni, Julie A Thompson, Jan L Shifren, Andrea L Zuckerman, Katherine Pereira

Menopause· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid Prescription and Patient Use After Gynecologic Procedures: A Survey of Patients and Providers.
Kendall C Griffith, Nisse V Clark, Andrea L Zuckerman, Tanaz R Ferzandi, Kelly N Wright

J Minim Invasive Gynecol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transition of care to an adult provider.
Andrea L Zuckerman

Curr Opin Obstet Gynecol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor.
Christina Charles-Schoeman, Pierre Wicker, Miguel A Gonzalez-Gay, Mary Boy, Andrea Zuckerman

Semin Arthritis Rheum· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
See, Test & Treat: A 5-Year Experience of Pathologists Driving Cervical and Breast Cancer Screening to Underserved and Underinsured Populations.
Barbarajean Magnani, Beth Harubin, Judith F Katz, Andrea L Zuckerman, William C Strohsnitter

Arch Pathol Lab Med· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Recommendation: Vulvovaginitis.
Andrea Zuckerman, Mary Romano

J Pediatr Adolesc Gynecol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist.
Christina Charles-Schoeman, Miguel A Gonzalez-Gay, Irina Kaplan, Mary Boy, Jamie Geier, Andrea Zuckerman

Semin Arthritis Rheum· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effect of tofacitinib on measured glomerular filtration rate in patients with active rheumatoid arthritis: results from a randomised controlled trial.
Joel M Kremer, Alan J Kivitz, Jesus A Simon-Campos, Evgeny L Nasonov, Hans-Peter Tony, Andrea Zuckerman

Arthritis Res Ther· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinib.
Christina Charles-Schoeman, Roy Fleischmann, Jean Davignon, Howard Schwartz, Scott M Turner, Andrea Zuckerman

Arthritis Rheumatol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trials.
John D Isaacs, Andrea Zuckerman, Sriram Krishnaswami, Chudy Nduaka, Shuping Lan

Arthritis Res Ther· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study.
Iain B McInnes, Ho-Youn Kim, Sang-Heon Lee, David Mandel, Yeong-Wook Song, Andrea Zuckerman

Ann Rheum Dis· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial.
Sripal Bangalore, Franz H Messerli, Chuan-Chuan Wun, Andrea L Zuckerman, David DeMicco

Eur Heart J· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
Michael J Koren, Michael H Davidson, Daniel J Wilson, Rana S Fayyad, Andrea Zuckerman

Am J Kidney Dis· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease.
James Shepherd, John P Kastelein, Vera A Bittner, Rafael Carmena, Prakash C Deedwania, Andrea L Zuckerman

Mayo Clin Proc· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular risk factors and dementia.
Howard Fillit, David T Nash, Tatjana Rundek, Andrea Zuckerman

Am J Geriatr Pharmacother· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study.
James Shepherd, John J P Kastelein, Vera Bittner, Prakash Deedwania, Andrei Breazna, Andrea Zuckerman

J Am Coll Cardiol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atorvastatin does not induce glomerular or tubular dysfunction even at high doses.
Murray Epstein, Elizabeth Leary, Rachel Laskey, Andrea Zuckerman, David Reed

J Cardiometab Syndr· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study.
James Shepherd, John J P Kastelein, Vera Bittner, Prakash Deedwania, Andrei Breazna, Andrea Zuckerman

Clin J Am Soc Nephrol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease.
William H Frishman, Andrea L Zuckerman

Expert Rev Cardiovasc Ther· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aldosterone plays a pivotal role in the pathogenesis of thrombotic microangiopathy in SHRSP.
Praveen N Chander, Ricardo Rocha, Jeffrey Ranaudo, Gagan Singh, Andrea Zuckerman

J Am Soc Nephrol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis